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Germinal Centers Still
Hold Secrets
There has been recent progress in understanding the r
mechanism of somatic hypermutation in germinal c
centers. By contrast, there is more theory than cer-
ttainty about the way those cells that acquire height-
e
ened affinity for antigen are subsequently selected.
qWang and Carter (2005) highlight this in the current
fissue of Immunity in a study of germinal center devel-
r
opment in mice with impaired CD19 signaling.
r
rDuring T cell dependent antibody responses, B cells
either grow as plasmablasts outside follicles, or, within
pfollicles, form germinal centers (GC). In GC, B cells se-
flectively introduce mutations into their immunoglobulin
dvariable region genes (Jacob et al., 1991). Cells with
paugmented affinity for the antigen are then selected by
aan antigen and T cell-dependent process and leave the
tGC either as antibody-producing cells or memory cells
v(MacLennan, 1994). This selection seems likely to re-
squire uptake of antigen via the B cells receptor for anti-
mgen (BCR) and subsequent presentation to local CD4 T
pcells. If this is so, the way the encounter with antigen
coccurs will have a critical influence on selection. Wang
Cand Carter (2005) describe how GC B cell selection is
zaltered in mice with mutant CD19 that has lost function
athrough disruption of PI3Kinase-binding sites. CD19 is
aexpressed on B cell progenitors as well as immature
and mature B cells. On mature B cells, it is linked to the
5C3d receptor — CD21. The CD19/CD21 complex plays a
tcritical role by adjusting the threshold for antigen-specific
lB cell activation (Tedder et al., 1997). Crosslinking CD21
awith the BCR greatly reduces the threshold for B cell acti-
ovation (Dempsey et al., 1996). Conversely CD19/CD21
tsequestration with anti-CD19 antibody increases the
sextent of BCR crosslinking required to activate B cells
t(Pezzutto et al., 1986). Thus, in the context of GC, im-
rpaired CD19 function might be expected to affect both
pthe induction of GC and the way GC B cells are se-
Slected. The mice with impaired CD19 signaling form
zGC, but these are markedly smaller in number and size
than those of congenic wild type controls. Somatic zypermutation is induced, but the frequency of muta-
ions identified in the immunoglobulin variable region
enes of GC B cells of deficient mice was about one
ifth normal. Canonical mutations that increase affinity,
hich are frequently found in wild type GC, were poorly
epresented in GC of the deficient mice. This seems
ounter intuitive because BCR signaling is reduced
hrough loss of CD19/CD21 function and this would be
xpected to increase the minimum BCR affinity re-
uired for selection. Perhaps the different repertoire
ound in the GC of CD19-impaired mice reflects a
aised affinity threshold for recruiting B cells into the
esponse. This could be compounded either by a lower
ate of proliferation or hypermutation or both of these.
The development of GC was also considered in this
aper. In common with earlier reports B cell growth in
ollicles is first apparent within the network of follicular
endritic cells (FDC). Later proliferating cells also ap-
ear at one pole of the GC. Conventionally the FDC rich
rea of the GC is the light zone and the B blasts outside
he FDC network occupy the dark zone. A novel obser-
ation indicates that the cells in the dark zone have
witched from IgM, while those in the light zone are a
ixture of switched and nonswitched cells. Further, the
roportion of nonswitched cells, particularly those
oexpressing IgD, is higher in GC of mice with impaired
D19 signaling. An exception to this finding is dark
one development in AID-deficient mice, which are un-
ble to switch immunoglobulin class (Muramatsu et
l., 2000).
On the basis of the location of nonswitched cells and
-bromo-2#-deoxyuridine uptake experiments, the au-
hors postulate that the B cells in the dark zone and
ight zone may be largely independent pools of prolifer-
ting cells. Further, they suggest that affinity maturation
ccurs in the light zone rather than the dark zone and
hat proliferation of light zone cells requires continued
ignals from immune complex, or other ligands on FDC
o survive, while those in the dark zone do not. This
aises the question about what this hypothetically inde-
endent pool of B blasts in the dark zone are doing.
ome published data indicate that at least some dark
one blasts move into the FDC network in the light
one. Exchange between these zones is implied from
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657single cell analysis in GC that shows members of the
same clone at different stages of mutation in the dark
zone and light zone (Küppers et al., 1993). Previous
5-bromo-2#-deoxyuridine pulse chase experiments in
rat GC indicate that B cells that have taken up label in
the dark zone during a 3 hr labeling period appear
in the light zone between 6 and 10 hr from starting la-
beling (Liu et al., 1991). Similar findings in mice were
reported by Hanna in 1964 (Hanna, 1964). The period
of postlabeling observation of Wang and Carter (2005)
was too brief to pick up this phenomenon. If cells in the
dark zone are to be selected it is hard to see how this
could happen in situ as antigen and T cells are not obvi-
ously present. The data cited above are consistent with
these cells passing into the light zone where they are
selected. In germinal centers induced in the absence
of T cells, dark zones form without the requirement for
T cell selection (Vinuesa et al., 2000). Presumably be-
cause antigen available for selection is absent, the B
cells in both the light zones and dark zones of these
GC undergo involution by mass B cell apoptosis within
5 days of GC induction. If dark zone B cells are not
moving to the light zone where they are selected, why
should this involution occur in such GC? Hypotheses
of the way affinity maturation occurs in GC set out
many years ago have been widely accepted, but are
not necessarily adequately tested. We must be grateful
to Wang and Carter (2005) for reminding us of the un-
certainty that exists about the way B cells are selected
during affinity maturation in GC.Ian C.M. MacLennan
MRC Centre for Immune Regulation
University of Birmingham
Birmingham B15 2TT
United Kingdom
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